Detail akcie McKesson online

Business Summary: McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, McKesson Corp revenues increased 16% to $359.05B. Net income increased 10% to $3.3B. Revenues reflect U.S. Pharmaceutical segment increase of 18% to $327.72B, International segment increase of 4% to $14.72B, Prescription technology solutions segment increase of 9% to $5.22B. Net income was partially offset by International segment loss totaling $213M vs. income of $319M.